We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > SPI

News List

SPI Pharma Launches UltraBurst contractpharma
July 13, 2021
SPI Pharma has introduced UltraBurst, providing a step-change in the most critical orally disintegrating tablet (ODT) characteristics—dissolution time. It is an innovative excipient platform for flash ODTs, enabling disintegration in under ten seconds.
CPhI Webinar: Trends and Advances in Patient Centric Drug Development - Watch On Demand cphi-online
June 24, 2021
Catch up on the latest trends and developments in patient centric drug development
Sound Pharmaceuticals Receives $3.1M NIH Grant for COVID Treatment contractpharma
April 08, 2021
Sound Pharmaceuticals, Inc. (SPI) has received a Cooperative Grant award from the National Center for Advancing Translational Sciences (NCATS) at the NIH for $3.1 milion to support the testing of SPI-1005 in two Phase 2 clinical trials for the ...
FDA Clears SPI’s Ebselen for Phase II COVID-19 Trials contractpharma
September 01, 2020
SPI-1005 is a novel anti-inflammatory drug which was recently shown to inhibit nCoV2 activity and viral replication.